Introduction
Nerve growth factor (NGF) belongs to the neurotrophin (NT) family that is involved in the functional regulation of many organs including nervous, immune and vascular systems. The NT family contains four members: NGF (Levi-Montalcini et al., 1996) , BDNF (brain-derived neurotropic growth factor) (Barde et al., 1987) , NT3 (Hohn et al., 1990) and NT4/5 (also known as NTF5) (Berkemeier et al., 1991) , which promote neuronal cell survival, differentiation and cell death (Huang and Reichardt, 2001 ). NTs are highly basic proteins that in the active, circulating stage form homodimers composed of non-covalently associated subunits with molecular masses of about 13 kDa (Bradshaw et al., 1993) . NGF is produced by the murine or rat submaxillary gland as a precursor complex (pro-NGF; also known as 7S) of about 130 kDa. This complex is composed of three subunits ␣, ␤ and ␥, which disassociate at a very acidic pH, enabling the isolation of the active ␤-subunit (Shooter, 2001) . The ␤-subunit, known as ␤-NGF (2.5S), is the active subunit of NGF and exhibits all of the biological activities classically described for NGF. The properties of ␣ and ␥ subunits are probably irrelevant to NGF functions because they have been only found in the mouse and rat submaxillary gland (Shooter, 2001) .
The neurotrophins have receptors on the cell surface that have been classified according to binding specificity. High affinity receptors belong to the class of tyrosine receptor kinases (Trks; also known as NTRKs, neurotrophic tyrosine kinase receptors), and NGF has been recognized as a specific ligand for TrkA (also known as NTRK1), BDNF and NT4 for TrkB (also known as NTRK2), and NT3 for TrkC (also known as NTRK3) (Chao, 2003) . The association of neurotrophins with these receptors usually leads to an increase of cell proliferation ratio and the induction of prosurvival mechanisms. Although prevention of neuronal death is one of the major functions of neurotrophins, in certain situations they may induce cell apoptosis (Frade and Brade, 1998) . This situation occurs when neurotrophins, especially NGF binds to the low affinity receptor p75 NTR . This receptor belongs to the tumor necrosis receptor family, and following association with the ligand induces an apoptotic signal. By contrast, p75 NTR (also known as NGFR) is also involved in the creation of a high affinity complex receptor with Trks and can enhance its specificity for neurotrophins (Bibel et al., 1999) . However, in the absence of Trks, p75 NTR acts as a death receptor indicating that neurotrophins function as cell survival-death regulatory factors. In this paper we report, for the first time, that ␣9␤1 integrin is a common low affinity receptor for neurotrophins, but in contrast to p75 NTR , it is involved in triggering pro-survival signals.
Integrins are cell surface receptors that in active form are composed of two subunits: ␣ and ␤. Currently, 18 ␣ and 8 ␤ subunits have been identified and they form, in a restricted manner, at least 24 heterodimers (Sheppard, 2000; Hynes, 2002) . Integrins are the major structural receptors that maintain proper tissue organization through cell-cell and cell-extracellular matrix (ECM) interaction. Despite having structural functions, integrins also participate in the transferring of cellular signals leading to modulation of cell death or survival, proliferation and migration (Frisch and Ruoslahti, 1997; Stupack and Cheresh, 2002) . Integrindependent adhesion to the ECM proteins increased the pro-survival ability of cells, whereas any detaching or adhesion to degraded ECM leads to induction of apoptosis. Cell signaling induced by integrins is also associated with cytoskeleton reorganization following cell spreading and migration (Hood and Cheresh, 2002; Liddington and Ginsberg, 2002) , as well as with modulation of cell The integrin ␣9␤1 is a multifunctional receptor that interacts with a variety of ligands including vascular cell adhesion molecule 1, tenascin C and osteopontin. We found that this integrin is a receptor for nerve growth factor (NGF) and two other neurotrophins, brain-derived neurotrophic factor and NT3, using a cell adhesion assay with the ␣9SW480 cell line. Interaction of ␣9␤1 with NGF was confirmed in an ELISA assay by direct binding to purified integrin. ␣9␤1 integrin binds to neurotrophins in a manner similar to another common neurotrophin receptor, p75 NTR (NGFR), although ␣9␤1 activity is correlated with induction of pro-survival and proproliferative signaling cascades. This property of ␣9␤1 resembles the interaction of NGF with a high affinity receptor, TrkA, however, this integrin shows a low affinity for NGF. NGF induces chemotaxis of cells expressing ␣9␤1 and their proliferation. Moreover, ␣9␤1 integrin is a signaling receptor for NGF, which activates the MAPK (Erk1/2) pathway. The ␣9␤1-dependent chemotactic ability of NGF appears to result from the activation of paxillin.
proliferation. These cell properties are important in the pathological changes and progression of many diseases including cancer angiogenesis and metastasis, autoimmune disorders, and cardiovascular diseases (Marcinkiewicz, 2005) .
The integrin ␣9 subunit has been identified as a heterodimer, only in association with the ␤1 subunit (Palmer et al., 1993) . The ␣ subunit of this integrin consists of a single polypeptide, whereas most ␣ subunits are composed of two chains. This integrin is widely distributed in the human body and is expressed on many types of cells including epithelial cells, muscle cells, neutrophils and endothelial cells (Palmer et al., 1993; Tarui et al., 2001; Vlahakis et al., 2005; Staniszewska et al., 2007) . The wide distribution of ␣9␤1 integrin could be related to its high crossreactivity with a variety of endogenous ligands such as vascular cell adhesion molecule 1 (VCAM1) (Taooka et al., 1999) , tenascin C (Yokosaki et al., 1998) , and osteopontin (Smith et al., 1996) . It was also characterized as a receptor for ADAM (a disintegrin and metalloproteinase) family protein members such as ADAM12 and ADAM15 by interaction with their disintegrin-like domain (Eto et al., 2002; Lafuste et al., 2005) . We also found that this integrin is a receptor for thrombospondin 1 (TSP-1; also known as THBS1) and has a binding site on the N-terminal (NoC1) domain of this ECM protein (Staniszewska et al., 2007) . Recently, ␣9␤1 integrin was also reported to interact with vascular endothelial growth factor isoforms (Vlahakis et al., 2005; Vlahakis et al., 2007) . The work presented in this paper showed that this integrin can directly interact with another growth factor, NGF, and induce proliferation and migration of cells.
Results
The wide distribution of ␣9␤1 integrin among mammalian tissues has been known for some time (Palmer et al., 1993) . These results obtained by immunostaining of frozen sections of a variety of mouse and human tissues were confirmed by us through western blot analysis (Fig. 1) . We focused on rat tissues that have been isolated from an adult female and lysed to obtain cell extracts for SDS-PAGE separation. We detected the ␣9 integrin subunit in all the tested organs except brain (Fig. 1Ae) . Interestingly, all lysates contained protein with a molecular mass of about 100 kDa that strongly cross-react with anti-␣9 antibody. This band is not related to a degradation product of the ␣9 subunit, because it is also present in mock-SW480 cells (Fig. 1Aa) . Therefore, we assume that this band is not associated with an interaction between polyclonal antibody and ␣9 integrin, but with a protein that contains fragments with an identical sequence to the cytoplasmic domain of this integrin subunit. The control IgG isolated from pre-bleed serum showed no cross reactivity with any proteins detected by anti-␣9 antibody, although some negligible bands were present in the lower molecular mass area of the gel (Fig. 1B) .
Interaction of ␣9␤1 integrin with NGF and other neurotrophins SW480 colon cancer cell line transfected with ␣9␤1 integrin potently adhered to immobilized NGF, whereas control mocktransfected cells showed no adhesion (Fig. 2) . The adhesion of ␣9SW480 cells was observed in a dose-dependent manner for two types of NGFs isolated from mouse submaxillary glands ( Fig. 2A) . Both low molecular mass mNGF (2.5S two ␤ subunit complex) and high molecular mass pro-NGF (7S NGF, three subunits ␣, ␤, ␥ complex), showed a similar pattern of adhesion although mNGF promoted adhesion at a significantly lower concentration than pro-NGF. Using preparations isolated from natural sources there is the possibility of nonspecific interactions because of contaminants that are difficult to remove during the purification process. To avoid this kind of misinterpretation of our results we compared the activity of mNGF with a human recombinant form of this growth factor. The adhesion of ␣9SW480 cells to mNGF and hrNGF was almost identical, showing no statistically important differences in the adhesion to a specific anti-␣9␤1 monoclonal antibody (clone Y9A2), or a well characterized ligand for this integrin, VCAM1. Adhesion of mock-transfected cells to both factors was negligible. Further, we explored the possibility of an interaction of ␣9␤1 integrin with other neurotrophins. We selected BDNF and NT3, which specifically interact with two other receptors TrkB and TrkC, respectively. Both neurotrophins potently interact with ␣9SW480 cells in adhesion assay to a similar extent as NGF, as well as another endogenous ligand for ␣9␤1 integrin, VCAM1 (Fig. 2B) . A little adhesion of mock cells was observed for BDNF, suggesting that the wild-type of colon adenocarcinoma SW480 cell line may contain a high affinity receptor for this neurotrophin, TrkB. Although there are no reports showing the presence of TrkB on colon cancer, the overexpression of this receptor was found in many other types of adenocarcinomas including lung, prostate and pancreas (Ricci et al., 2001; Desmet and Peeper, 2006) . The adhesion of cells expressing ␣9␤1 integrin to immobilized neurotrophins was dependent on divalent cations. Elimination of calcium and magnesium from the reaction buffer abolished adhesion of ␣9SW480 cells to NGF, BDNF and NT3 (data not shown). The specificity of the interaction between NGF and ␣9␤1 integrin in adhesion assays was also confirmed in competition studies (Fig. 2C) . Adhesion of ␣9SW480 cells was inhibited by blocking with anti-␣9␤1 and anti-␤1 monoclonal antibodies, whereas blocking antibodies against other integrins expressed on the SW480 cell line such as anti-␣5␤1 and anti-␣v␤3 had no inhibitory effect. Snake venom MLD-disintegrin, VLO5 that antagonizes ␣4␤1 and ␣9␤1 integrins, also inhibited adhesion of ␣9SW480 cells to NGF. However, snake venom disintegrin VLO4 that potently binds to ␣5␤1 integrin through its RGD motif had no effect on ␣9␤1-NGF interaction. ␣4␤1 and ␣9␤1 integrins show a high level of structural homology and share some ligands including VCAM1. We tested the possibility of an interaction between ␣4␤1 integrin and NGF in an adhesion assay using two cell lines, Jurkat and Ramos, which both highly express this integrin. However, our results did not show any cross-reactivity of these cell lines with NGF (data not shown). Interaction of NGF with ␣9␤1 integrin was confirmed using an activating anti-LIBS (ligand-induce binding site) antibody. In the adhesion assay, mNGF and VLO5 significantly increased the binding of ␣9SW480 cells to anti-␤1 (B44) monoclonal antibody, reflecting induction of conformational changes in the integrin (Fig. 2D) .
The direct binding of NGF to ␣9␤1 integrin was monitored by ELISA (Fig. 3) . In this assay, we reversed the immobilization strategy used in cell adhesion, coating the plate with purified integrin. The soluble NGF also bound to ␣9␤1 integrin in a doseJournal of Cell Science 121 (4) dependent manner showing saturation at a concentration below 1 g/ml. The calculated K d in this assay was 4.5±0.8 nM (±s.d.) . In this experiment we used hrNGF instead of mNGF to excluding any non-specificity related to trans-specie interaction. This result indicated that NGF is a very specific ligand for ␣9␤1 integrin interacting in both soluble and immobilized forms. We used ␣9␤1 integrin purified from another ␣9-transfected cell line, K562, in the ELISA assay, to show that this interaction is not just related to one cell line. Regarding this point, we should mention that in an adhesion assay ␣9K562 cells also adhere to immobilized NGF, as well as other cell lines, including G361 melanoma and LN229 glioblastoma that naturally express ␣9 integrin (data not shown).
Identification of TrkA and p75
NTR on SW480 cells
Integrin ␣9␤1 in the context of its direct interaction with NGF appears to be a signaling receptor that may regulate cell functions such as migration and proliferation. However, investigation of these functions that depend on ␣9␤1-NGF interaction required the elimination of other NGF receptors involved in these processes.
Using RT-PCR analysis we found the presence of two other NGF receptors, TrkA and p75 NTR at the mRNA level in SW480 cells. Interestingly, the amount of TrkA mRNA in mock-SW480 cells was similar to that in human neuroblastoma cell line (SH-SY5Y), Monoclonal antibodies Y9A2 (anti-␣9␤1), Lia1/2 (anti-␤1), SAM-1 (anti-␣5) LM609 (anti-␣v␤3), or snake venom disintegrins at concentrations of 10 g/ml, were preincubated with CMFDA-labeled cells for 15 minutes before adding to the wells for adhesion. Adhesion experiments were performed as described above.
(D) Effect of mNGF and VLO5 on expression of LIBS epitope on the ␤1 subunit of integrin in ␣9SW480 cells. Anti-LIBS, anti-human monoclonal antibody (B44), was immobilized in 96-well plates at a concentration of 10 g/ml in PBS, overnight at 4°C. VLO5 or mNGF at a concentration of 1 M was preincubated with CMFDA-labeled ␣9SW480 cells for 15 minutes before addition to the wells for adhesion. Adhesion experiments were performed as described above. Error bars indicate the standard deviation from three independent experiments.
whereas it was significantly downregulated in cells transfected with ␣9 integrin subunit (Fig. 4A,B) . The RT-PCR results were confirmed by western blot analysis of these cell lysates with polyclonal antibody against TrkA (Fig. 4D) . The radioreceptor binding studies of 125 I-NGF with cells revealed a strong interaction of this growth factor with rat neuronal cells (PC12 cell line) and a negligible interaction with mock-and ␣9SW480 cell lines (Fig.  4C ). High expression of TrkA protein was observed in the PC12 cell (Fig. 4Da) . Since the affinity of 125 I-NGF to cell binding sites is very high (around 10 -11 M), the activity of this reagent only reflects the interaction with the high affinity complex receptor TrkA-p75 NTR . Therefore, the binding of the low affinity receptors p75 NTR and ␣9␤1 integrin to 125 I-NGF was not reflected in the value measured. The very low density of 125 I-NGF binding sites on the SW480 cell lines compared with PC12 neuronal cells, is probably not sufficient to support NGF-induced, TrkA-mediated signals as previously observed . Lack of competition of NGF with VLO5 in binding assay with neuronal cells further supports the conclusion that this disintegrin is not an antagonist of TrkA and its inhibitory effects are strictly mediated by ␣9␤1 antagonism.
Binding of NGF activates an ␣9␤1 integrin-dependent pathway of cell signaling
Previously published studies revealed that ␣9␤1 integrin is involved in the activation of a signaling pathway that includes phosphorylation of Erk1/2 (MAPK) and paxillin (Young et al., 2001; Vlahakis et al., 2005) . NGF as an immobilized ligand for ␣9␤1 integrin activates both signaling molecules following the adhesion to ␣9SW480 cells (Fig. 5) . However, in the presence of ␣9␤1 integrin inhibitors such as Y9A2 and VLO5, phosphorylation of Erk1/2 (Fig. 5A) and paxillin (Fig. 5B) was significantly decreased. Interestingly, activation of Erk1/2 was strongly inhibited by VLO5, whereas a much more potent inhibitory effect of Y9A2 was observed for paxillin phosphorylation. The increased activation of these proteins was not observed for mock-SW480 cells (data not shown). The NGF-induced, ␣9␤1 integrindependent signal transduction was confirmed with the GD10 cell line. In this experiment we used soluble mNGF for the stimulation of the cells in the culture. Co-transfection of this cell line with ␣9 and ␤1 integrin subunits revealed significant increase of Erk1/2 phosphorylation as a response to stimulation with NGF in comparison with wild-type cells (Fig. 5C) . However, integrin with a hybrid ␤ subunit (␤1/␤3), which is composed of a ␤1 extracellular and transmembrane domain and a ␤3 cytoplasmic domain, showed no significant NGF-induced Erk1/2 phosphorylation.
Chemotaxis of ␣9␤1 integrin-expressing cells induced by NGF
NGF appeared to be a potent inducer of the migration of ␣9SW480 cells (Fig. 6A) , whereas mock-SW480 cells migrated toward this growth factor at the random level (data not shown). The migratory properties of cells strongly depend on the concentration of NGF and the time of migration. The lower concentrations (2.5 and 5 g/ml) of NGF produced maximum migration at 4 hours, whereas at higher concentrations (10 and 20 g/ml) maximum migration occurred at 2 hours. Y9A2 was significantly effective in blocking migration of ␣9SW480 cells to mNGF (5 g/ml), whereas the effect of VLO5 was not significant (Fig. 6B) . As negative controls for this assay, neutral mouse IgG and the disintegrin eristostatin were used, because they do not cross-react with any receptor on SW480 cells. Eristostatin is a specific disintegrin for platelet fibrinogen receptor, ␣IIb␤3 integrin (Marcinkiewicz et al., 1996) .
␣9␤1 integrin-dependent cell proliferation induced by NGF
The proliferation of cells expressing ␣9␤1 integrin was potently induced by hrNGF in a dose-dependent manner, showing a saturation point at 250 ng/ml (Fig. 7A) , whereas proliferation of mock-SW480 cells was not changed by this growth factor. This clear difference between ␣9-transfected cells and mock-transfected cells suggests that binding of NGF to ␣9␤1 integrin is involved in the induction of cell proliferation. To reach the saturation point of mNGF in proliferation experiment required using more than a fourfold higher concentration of this growth factor (up to 1 g/ml). This species selectivity was observed in ELISA (Fig. 3) , because using hrNGF and purified human receptor increased affinity about 100-fold when compared with mNGF. NGF-induced proliferation of ␣9SW480 cells is dependent on its interaction with ␣9␤1 integrin, because inhibitors of this integrin, Y9A2 and VLO5 blocked this process to the level of non-stimulated cells (Fig. 7B) . In the proliferation experiment, we used mNGF (1 g/ml) to show that the blocking of ␣9␤1 integrin is independent of the source of NGF, although the same inhibitory results were obtained for hrNGF. Vincristine was used as a positive control in this assay, and neutral IgG and eristostatin were negative controls. The polyclonal blocking serum against TrkA showed no effect on proliferation of ␣9SW480 cells, suggesting that the major NGF receptor on these cells is ␣9␤1 integrin. The ␣9␤1 integrin-dependent proliferation induced by mNGF was also confirmed by transient transfection of Fig. 3 . Binding of mNGF to purified ␣9␤1 integrin in ELISA assay. ␣9␤1 integrin isolated from ␣9K562 cells was immobilized in a 96-well plate at a concentration of 0.5 g/ml by overnight incubation at 4°C in PBS. After blocking with 5% non-fat milk, a range of concentrations of hrNGF were added to the wells, which were incubated for 30 minutes at 37°C. The wells were then washed, and bound ligand was detected by adding the primary anti-NGF polyclonal antibody and incubation for 60 minutes at 37°C. After washing, the goat anti-rabbit alkaline-phosphatase (AP)-conjugated IgG was added and incubation was continued for another 60 minutes at 37°C. The color was developed with AP substrate (4-nitrophenylphosphate) and the plate was read using an ELISA plate reader at a 405 nm single wavelength. The specific binding (᭡) was estimated by subtraction of binding of NGF to the blocker (᭺) from binding of NGF to immobilized integrin (᭹). The error bars represent the standard deviation from three duplicated independent experiments.
expressing ␤1 with the ␣9 subunit also confirmed that signals transferred through ␣9␤1 integrin in response to NGF are not associated with any degeneration of ␣9SW480 cells with long-term culture.
Chemotaxis of human neutrophils to ␣9␤1 integrin ligands
Previous reports described the expression of ␣9␤1 integrin on neutrophils and the participation of this integrin in migration of these granulocytes (Taooka et al., 1999; Marcinkiewicz et al., 2000) . In the presented work, we tested different ␣9␤1 integrin ligands, including NGF as possible chemoattractants for neutrophils (Fig. 8A ). NGF appears to be a potent inducer of cell migration with levels similar to those of the disintegrin VLO5 or of Y9A2, a monoclonal antibody against ␣9␤1 integrin. As a positive control 2% FBS was used. Transmigration of neutrophils to mNGF was blocked by Y9A2 monoclonal antibody, whereas the inhibitory effect of VLO5 in this assay was not significant (Fig.  8B ).
Discussion
In this study we found that neurotrophins such as NGF, BDNF and NT3 contain a third common receptor, ␣9␤1 integrin. Currently characterized receptors for these molecules belong to the highly specific tyrosine kinase family (Trks), and common to all the neurotrophins, the low affinity receptor p75 NTR . Very specific interaction of this integrin with these three molecules was observed in adhesion assays of cells transfected with the ␣9 integrin subunit, verifying the expectation that ␣9␤1 integrin is another common,
Journal of Cell Science 121 (4)
low affinity receptor for neurotrophins similar as p75 NTR . However, these two cell surface receptors, following binding to NGF appeared to show completely opposite functions. Integrin induces pro-proliferative and pro-migratory activity of cells, whereas p75 NTR is involved in transferring pro-apoptotic signals. Interaction of NGF with ␣9␤1 does not require any integrin stimulators or binding enhancers such as monoclonal antibodies (e.g. TS2/16) or high concentrations of Mn 2+ (Bazzoni et al., 1995; Byzova and Plow, 1998) . This observation increases the relevancy of ␣9␤1-neurotrophin interaction in the physiology and pathology of various organs.
The deficiency of this integrin on brain cells (Fig. 1 ) (Staniszewska et al., 2007 ) is a little intriguing in the context of our major discovery that it is a receptor for neurotrophins. This suggests that the interaction of NGF with ␣9␤1 integrin does not have a regulatory effect on the central nervous system, however, it may influence the physiology of other organs affecting the peripheral nervous system. The binding of neurotrophins to ␣9␤1 integrin may be important in the development of pathology in the brain. A majority of malignant gliomas express this integrin and NGF potently induces ␣9␤1-dependent proliferation and invasion of these cancer cells (our unpublished data).
The binding of NGF to ␣9␤1 integrin is promoted similarly to other natural ligands such as VCAM1 or ECM proteins. The necessity of divalent cations for this interaction indicates that subunits of ␣9␤1 need to form an active conformation of their ligand binding pocket. This requirement is strictly essential for specific integrin-ligand interactions in cell physiology. Moreover, the ability of NGF to induce the LIBS epitope on the ␤ subunit of ␣9␤1 exhibits a similar mechanism of binding to integrins as endogenous (ECM) and exogenous (disintegrins) ligands, which in association with their receptor express a neo-epitope that is recognized by an anti-LIBS antibody (Marcinkiewicz et al., 1997) . Finally, the ELISA assay confirmed the direct binding of hrNGF to ␣9␤1 integrin in a manner opposite to that of immobilized mNGF and integrin in solution. Interestingly, we found species selectivity for soluble neurotrophin in ELISA. Experiment with hrNGF showed two orders of magnitude of increasing binding affinity in comparison with mNGF (K d 4.5 vs 440 nM). By contrast, NGF in the immobilized form appears to have species-independent pro-adhesive properties for cells expressing ␣9␤1 integrin, suggesting that ligand-receptor interaction in the solid phase may have different conformational requirements.
We found in cell migration and proliferation assays, the importance of ␣9␤1-NGF interaction in cell physiology. Young et al. (Young et al., 2001) reported that the cytoplasmic domain of the ␣9 integrin subunit may be important in enhancing the rate of cell migration, which agrees with the ␣9␤1 integrin-dependent pro- Fig. 5 . ␣9␤1 integrin-dependent signaling induced by mNGF. (A) ␣9SW480 cells were allowed to adhere to immobilized mNGF (20 g/ml) or BSA for 30 minutes in the absence or presence of ␣9␤1 integrin inhibitors, Y9A2 (10 g/ml) or VLO5 (10 g/ml). Cell lysates were obtained and equal amounts of protein were separated under reducing conditions by 10% SDS-PAGE. The proteins from the gel were electro-transferred onto a PVDF membrane and incubated with primary anti-phospho-Erk1/2 (Thr202/Tyr204) and anti-Erk1/2 polyclonal antibodies. The bands were visualized using chemiluminescent western detection kit. The numbers above the bands represent the average number of pixels, reflecting intensity of the bands in the presented scans, digitalized using Un-ScanIt gel software. (B) Paxillin phosphorylation in ␣9SW480 cells induced following binding to immobilized mNGF. Anti-phospho-paxillin (Tyr31) and anti-paxillin polyclonal antibodies were used. (C) Effect of mNGF on phosphorylation of Erk1/2 in GD10 cells transfected with ␤1 subunit or hybrid ␤1/␤3 subunit and co-transfected with ␣9 integrin subunit. Cells were cultured on the plate and stimulated with or without mNGF (50 ng/ml) for 1 hour. Cells were lysed and detection of phosphor-Erk1/2 and total Erk1/2 was performed as described above. All signaling experiments were repeated at least three times. migratory activity of NGF. However, the mechanism that involves ␣9␤1 integrin in the promotion of cell migration is still unclear.
Our results confirmed that ␣9␤1 integrin, following binding to its ligand NGF, induces activation of a focal adhesion adaptor protein, paxillin (Fig. 4B) . Binding of paxillin to the ␣9 subunit is sufficient to modulate cell spreading, but it has no effect on the regulation of cell migration. However, using two different inhibitors of this integrin, we observed a correlation between phosphorylation of paxillin and cell migration. The NGF-dependent chemoattraction of ␣9SW480 cells was potently inhibited by blocking with an anti-␣9␤1 monoclonal antibody, whereas the effect of the MLDdisintegrin, VLO5 was not significant. The same activity of ␣9␤1 integrin inhibitors was obtained in the transmigration assay of human neutrophils. Accordingly, inhibition of NGF-induced paxillin phosphorylation was more potently inhibited by Y9A2 than by VLO5. These data may suggest that growth factor-induced
␣9␤1 integrin-dependent cell migration is associated with paxillin activation, whereas extracellular matrix (Tenascin-C)-induced cell migration is paxillin independent (Young et al., 2001) . Further work with paxillin-deficient cells will verify this hypothesis. The major difference between ␣9␤1 and the other common receptor for neurotrophins, p75 NTR , is an effect on cell proliferation. p75 NTR without association with TrkA is an inhibitor of this process and an inducer of pro-apoptotic signals (Lee et al., 2001) . Following binding to ␣9␤1, NGF induces the activation of MAPK Erk1/2, which is generally characterized as a signaling molecule mediating pro-proliferative and pro-survival signals. Interestingly, this growth factor caused increased phosphorylation of Erk1/2 only in transfected cells expressing ␣9␤1 integrin, whereas no effect was observed in control cells. The ␣9␤1-dependent mediation of cell signaling upon binding to NGF was also confirmed by specific integrin inhibitors, as well as by interaction with GD10 cells transfected with ␣9 subunit and hybrid ␤1/␤3 subunits. VLO5 and Y9A2 significantly decreased Erk1/2 phosphorylation in ␣9SW480 cell adhesion to immobilized NGF, whereas soluble NGF increased signal transduction in GD10 cells transfected with wild-type ␣9␤1 integrin. This effect was not observed in the cells that were transfected with a hybrid ␤ subunit containing extracellular and transmembrane domains from ␤1 and the cytoplasmic domain from ␤3 subunit. It suggests that NGF, similarly to ECM proteins (e.g. fibronectin) (Danen et al., 2002) , induces cell signaling pathways through the ␤1 subunit of the integrin. The signal transduction activity links ␣9␤1 integrin with the high affinity NGF receptor, TrkA, which is also involved in transferring signals inside the cells utilizing the Erk1/2 pathway (Edsjo et al., 2001; Slack et al., 2005) . In this context, expression of p75 NTR appears to be less important, because this is a pro-apoptotic receptor that is not involved in the stimulation of cell proliferation and Erk1/2 signaling. Although RT-PCR and western blot results showed a very low expression of TrkA on ␣9SW480 cells, and a radioisotope study confirmed an almost entire lack of high affinity-dependent interaction of these cells with NGF, we are not able to exclude the possibility that both receptors may cooperate in signal transduction. In this context, the observation that cells transfected with ␣9 integrin subunit significantly decrease expression of TrkA is very interesting. It may suggest that both NGF receptors are in a functional relationship and the deficiency of one is compensated by the other. Although blocking experiments with anti-TrkA serum and TrkA siRNA (data not shown) proved that ␣9␤1 integrin is independent in transferring pro-survival signals, the possibility of participation of TrkA in the cross-talk with this integrin may occur under certain physiological conditions.
Previously published reports showed a high and selective expression of ␣9␤1 integrin on neutrophils and the involvement of this integrin in chemotaxis of these granulocytes across an activated endothelial monolayer (Taooka et al., 1999; Marcinkiewicz et al., 2000) . Our findings may contribute to the explanation of mechanisms that are involved in NGF-dependent interaction of neutrophils in the progression of certain autoimmune diseases. Increased NGF levels have been observed in various inflammatory states including asthma (Braun et al., 1999) and arthritis (Aloe et al., 1992) and this upregulation was associated with a significant influx of neutrophils. Gee et al. (Gee et al., 1983 ) also observed activity of NGF as an inducer of polymorphonuclear leukocyte chemotaxis at nanomolar concentrations. However, the mechanism of this promigratory effect was not evaluated. The interaction of NGF with integrin as proposed by us may contribute to the explanation of this phenomenon. Another very important pathology induced by NGF is thermal hyperalgesia. Injection of NGF into experimental animals induced neutrophil accumulation and hyperalgesia in skin (Bennett et al., 1998) . A recent report showed that the involvement of certain integrins, especially the ␤1 subunit, is important in developing mechanical hyperalgesia induced by NGF (Malik-Hall et al., 2005) . However, NGF protected murine neutrophils from apoptosis and enhanced their survival (Kannan et al., 1991) . Based on the data presented in this work the mechanism of neutrophil accumulation and induction of pro-survival signals may be dependent on the interaction of NGF with ␣9␤1 integrin.
NGF has been detected in body fluids as well as in a majority of tissues, but in different concentrations (Katoh-Semba et al., 1989) . Our finding that ␣9␤1 integrin binds this growth factor in immobilized and soluble form suggests the availability of this receptor-ligand interaction in circulatory systems and solid tissues of the body. Published studies show that the effective concentration of NGF required to stimulate neurite outgrowth in vitro is in the range of 10-100 ng/ml (Levi-Montalcini, 1982) , whereas the NGF level in blood plasma was estimated to be approximately 100 pg/ml. Therefore, this in vitro activity that is dependent on a high affinity NGF receptor, TrkA, requires a concentration of NGF at least a two orders of magnitude higher than those observed in vivo. The affinity interaction of isolated human recombinant ␣9␤1 integrin with hrNGF in ELISA (K d =4.5 nM) is in the same range as for p75 NTR , which was K d =1.4 nM in a Scatchard analysis of 125 I-NGF binding to cells expressing this receptor (Hempstead et al., 1991) . The same radioactive analysis showed K d =25 pM for a high affinity complex of TrkA. Therefore, the concentrations of NGF that we used in our in vitro experiments corresponds to this ratio, because ␣9␤1 integrin is a low affinity receptor and in all cell signaling and proliferation experiments its effective doses did not exceed 1 g/ml. Higher amounts of mNGF used in the cell migration and adhesion assays resulted from specificity of assays. Immobilization of protein on the plastic is not 100%, especially for proteins of low molecular mass, such as NGF.
Materials and Methods

Antibodies, neurotrophins, snake venom disintegrins
Anti-␣9␤1 integrin (clone Y9A2) monoclonal antibody was prepared as described previously (Wang et al., 1996) and kindly provided by D. Sheppard (University of California, San Francisco, CA). Anti-␣5 (SAM-1) and anti-␤1 (Lia1/2) were purchased from Beckman Coulter Inc. (Fullerton, CA) ; anti-␤1 (B44) and anti-␣v␤3 (LM609) was purchased from Chemicon (Temecula, CA). Antibodies against signaling molecules were purchased as follow: anti-pErk (Thr202/Tyr204) and antiErk polyclonal antibodies (Cell Signaling Inc., Beverly, MA), anti-p-paxillin (Tyr31) (Biosource, Camarillo, CA), anti-paxillin (Chemicon). Anti-TrkA polyclonal serum was kindly provided by L. Reichardt (University of California, San Francisco, CA). Polyclonal serum against the ␣9 subunit of the integrin cytoplasmic domain was developed in a rabbit. The synthetic peptide representing the entire amino acid sequence of the cytoplasmic domain was used as an antigen. The development of this polyclonal antibody was performed commercially by Chemicon. Control, neutral mouse and rabbit IgGs, and human recombinant FGF were purchased from Sigma Inc. (St Louis, MO). All neurotrophins, native and recombinant, were purchased from PeproTech Inc. (Rocky Hill, NJ). Two snake venom dimeric disintegrins, VLO4 and VLO5 were purified from the venom of Vipera lebetina obtusa using two steps of reverse phase HPLC, as described previously (Bazan-Socha et al., 2004) and monomeric disintegrin eristostatin was purified using the same method from Eristocophis macmahoni venom (Latoxan, Valence, France).
Cell lines and transfection
␣9-and mock-transfected SW480 cells were kindly provided by D. Sheppard. Cells were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 1% penicillin-streptomycin and 1 mg/ml G418 (Mediatech Inc., Herndon, VA). ␣9K562 cells were provided by P. Weinreb (Biogen Inc.) and cultured in RPMI-1640 medium containing 10% FBS, 1% penicillinstreptomycin supplemented with 1 mg/ml G418. Rat pheochromacytoma PC12 and human neuroblastoma SH-SY5Y neuronal cells were kindly provided by G. Guroff (NIH, Bethesda, MA) and grown in DMEM supplemented with 7.5% horse serum, 7.5% FBS and DMEM supplemented with 10% FBS, respectively. GD10 cells deficient in the integrin ␤1 subunit (Bae et al., 2004) as well as cells transfected with the ␤1A splice variant gene ␤1A-GD10 (Wennerberg et al., 1996) and ␤1A/␤3-GD10 (Danen et al., 2002) were provided by D. Mosher (University of Wisconsin, Madison, WI). Stable transfectants were grown in media containing 10 g/ml puromycin. The pBlueScript (BS)-SK␣9 cDNA construct (Yokosaki et al., 1994) for transient transfection of cells with ␣9 integrin subunit, was provided by D. Sheppard. Lipofectamine (Invitrogen, Carlsbad, CA) was used for transfection of GD10, ␤1A-GD10 and ␤1A/␤3-GD10 cells with pBlueScript (BS)-SK␣9 cDNA plasmid according to the manufacturer's instruction. After 72 hours ␣9-GD10 cells were selected with 1 mg/ml G418, whereas ␣9␤1A-GD10 and ␣9␤1A/␤3-GD10 cells were selected with 1 mg/ml G418 and 10 g/ml puromycin.
Analysis of ␣9 integrin subunit expression in rat tissues by western blot
The various tissues were removed from an adult female rats and washed with icecold PBS containing protease inhibitors (Sigma). Tissues were cut into small pieces and incubated at room temperature for 30 minutes in lysis buffer containing 50 mM Tris-HCl pH 7.4, 150 mM NaCl, 5 mM EDTA, 1% Triton X-100, 25 mM NaF, 10% glycerol, 1 mM PMSF, 1 mM Na 3 VO 4 . Insoluble debris were removed by centrifugation and the supernatant was separated (20 g proteins per sample) on a 7.5% SDS-PAGE under reducing conditions. The protein bands were electrotransferred into a PVDF membrane (Millipore, Billerica, MA). The membrane was blocked with 5% non-fat milk in TBST and probed with anti-␣9 integrin subunit polyclonal antibody. After washing, the membrane was incubated with HPconjugated secondary antibodies and developed using chemiluminescence (Cell Signaling Inc.).
